ARCHIVES

ODAC Oks Carboplatin As 1st Line Ovarian Therapy; Other Drugs

This article is from The Cancer Letter archive.

Vol. 17 No. 28 | July 12, 1991

Download PDF Visit The Full Archive

Related Articles

Research Needed On Hormonally Active Agents, Report Finds

August 6, 1999

DRCCA Board Approves Concepts Of Four New Antismoking Projects

May 20, 1983

Bishop: Cells, Genes Reveal Unified Strategy For Cancer Conquest

March 3, 1995

NCI Advisors To Gain Increased Responsibility For Concept, Technical Merit Review Of Contracts

December 19, 1980

Randomization With Options Stimulates Sedmental Accrual

February 22, 1980

In Brief: Kripke, Fidler To Leave FCRF for M.D. Anderson; George Todaro Takes Job With New Seattle Firm

March 4, 1983